This article is more than 5 years old. Information may no longer be current.

Cynosure receives 510(k) clearance for PicoSure 532-nm laser delivery system

Cynosure announced today that the FDA has granted 510(k) clearance to its new PicoSure 532-nm laser delivery system, which will provide a dual-wavelength laser system for removing tattoos of all colors.

“The integration of the 532-nm wavelength into the PicoSure platform allows for more effective removal of red, orange and yellow tattoo ink, which can now be cleared in fewer treatments,” Roy G. Geronemus, MD, director of the Laser & Skin Surgery Center of New York, said in a Cynosure press release. “I believe that the combination of PicoSure’s 755-nm and 532-nm wavelengths provides unmatched tattoo clearance across the full color spectrum.”

The new 532-nm laser delivery system builds upon the success of the 755-nm PicoSure for the removal of tattoos and benign pigmented lesions, as well as for the treatment of acne scars and wrinkles, the release stated.

The new system will be introduced at the American Academy of Dermatology’s annual meeting on March 20-24 in San Francisco, with initial shipments expected to begin in the second quarter of 2015, according to the release.

Reference: www.cynosure.com.